Archives

LEO Pharma connects partners with Veeva-Vault Safety to transform security operations

LEO Pharma

Veeva Systems announced that LEO Pharma , a global leader in medical dermatology, is using Veeva Vault Safety to optimize its safety operations. With this foundation, the company can seamlessly integrate partner companies into security operations, increase operational efficiency, ensure regulatory compliance and unify its global pharmacovigilance data on one platform.

“LEO Pharma is deeply committed to the safety of patients who use its products,” said Pilar Carrero , vice president of global safety at LEO Pharma. “With Veeva Vault Safety, we now have real-time visibility into adverse events and data transparency for partners who help us help us work together even better.”

Vault Safety helps LEO Pharma improve control over case intake, processing, submission and distribution while simplifying security operations and eliminating metrics validation with affiliates and partners. By standardizing drug development in the Veeva Development Cloud, LEO Pharma can better connect safety with other key business areas such as clinical, regulatory and quality areas.

Also Read: Spacelabs Healthcare Expands Clinical Informatics Capabilities with Acquisition of Predictive Analytics Company PeraHealth

“Now all parties have visibility into case data, ownership and status, allowing for better collaboration and sharing learnings,” said John Lawrie, vice president of Vault Safety at Veeva. “Veeva is pleased to partner with LEO Pharma to improve their security operations simpler and more effective.”

Vault Safety is a modern drug safety case management system that enables end-to-end receipt, processing and submission of adverse events for clinical and marketed products. It is part of the Veeva Development Cloud, the technology foundation for drug development that brings together clinical, regulatory, safety and quality applications to drive end-to-end business processes.

Veeva is the world’s leading provider of cloud-based software solutions for the life sciences industry. Committed to innovation, product quality and customer success, Veeva serves more than 1,000 customers, from the world’s largest biopharmaceutical companies to emerging biotech companies. As a public benefit corporation , Veeva is committed to considering the interests of all stakeholders, including customers, employees, shareholders and the industries in which it operates.